From Therapeutics to Agriscience: Analyzing the Expanding Non-Human Applications and Revenue Diversification in the Gene Editing Market.
  While the most visible and high-value segment of the gene editing market is human therapeutics, the technology’s utility extends powerfully into non-human applications, creating a robust and rapidly growing revenue stream in agrigenomics and industrial biotechnology. Gene editing, particularly CRISPR, allows scientists to precisely engineer desirable traits in crops and livestock,...
0 Comments 0 Shares 1K Views 0 Reviews